Superselective transarterial radioembolization for the treatment of hepatocellular carcinoma
Superselective transarterial radioembolization (TARE) refers the delivery of Y90 at the tumor-feeding segmental or subsegmental arteries. The purpose of TARE would be delivering high dose in the tumor while saving as much normal parenchyma as possible. This concept is similar to the radiation segmen...
Saved in:
Main Author: | Gyoung Min Kim (Author) |
---|---|
Format: | Book |
Published: |
Society of Gastrointestinal Intervention,
2021-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Concurrent transarterial radioembolization and combination atezolizumab/bevacizumab treatment of infiltrative hepatocellular carcinoma with portal vein tumor thrombosis: a case report
by: Min Kyung Park, et al.
Published: (2022) -
Preparation and In Vitro Evaluation of Neutron-Activated, Theranostic Samarium-153-Labeled Microspheres for Transarterial Radioembolization of Hepatocellular Carcinoma and Liver Metastasis
by: Yin How Wong, et al.
Published: (2019) -
Radioembolization for hepatocellular carcinoma: what clinicians need to know
by: Jin Woo Choi, et al.
Published: (2022) -
Transarterial radioembolization: a systematic review on gaining control over the parameters that influence microsphere distribution
by: T. J. Snoeijink, et al.
Published: (2023) -
Superselective ablative chemo-ethanol embolization for recurrent single hepatocellular carcinoma: a 6-month outcome analysis
by: Jae Hwan Lee, et al.
Published: (2024)